India just quietly set one of its biggest economic targets of the decade.
And almost no one is talking about it.
NITI Aayog has dropped a roadmap to turn India into a $691 billion bioeconomy by 2035.
And a jaw-dropping $2.6 trillion by 2047.
For context — the sector was just $10 billion in 2014.
Today? $195.3 billion.
That's a 16x jump in 11 years. 🤯
The roadmap picks its champions clearly.
👉 Hyderabad. 👉 Bengaluru.
Twin engines. One mission.
Hyderabad brings the muscle:
Bengaluru brings the brains and the startup DNA.
Together — they could rewrite where global biomanufacturing actually happens.
NITI Aayog isn't asking politely.
It's proposing a ₹50,000 crore growth fund and six National BioMissions to fire this up.
States are already racing.
Telangana, Karnataka, Gujarat — subsidised land, single-window clearances, tailored incentives.
Everyone wants a piece of the biotech pie.
And the sector already contributes 4.8% of India's GDP.
Globally? The bioeconomy could hit 12–13% of world GDP by 2050.
Every major power has picked a lane:
India's lane? Manufacturing-first, incentives-heavy, talent-rich.
Bioeconomy isn't just vaccines and medicines.
It's biofuels. Bioplastics. Lab-grown materials. AI-designed proteins. Precision agriculture. Synthetic biology.
The stuff of the next industrial revolution.
And if the plan lands — it could create 30 million+ high-value jobs.
That's not a policy document.
That's a generational shift.
Everyone's obsessing over India's software story.
Meanwhile, the country is quietly loading a second barrel.
Silicon built the last two decades.
Cells, enzymes and molecules might build the next two.
And Hyderabad and Bengaluru just got handed the keys.
That's all for now!
